Endurant Capital Management LP Adc Therapeutics Sa Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$5.96 - $14.99 $351,443 - $883,915
58,967 New
58,967 $469,000
Q4 2020

Feb 16, 2021
SELL
$25.26 - $38.02 $303,120 - $456,240
-12,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$32.87 - $51.05 $249,483 - $387,469
7,590 Added 172.11%
12,000 $396,000
Q2 2020

Aug 14, 2020
BUY
$29.65 - $46.81 $130,756 - $206,432
4,410 New
4,410 $206,000

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $155M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email